Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 6, 2016, Pages 670-675

  Singh, Rashmi ^a   Savitz, Jonathan ^a,b   Teague, T Kent ^c,d,e   Polanski, David W ^b   Mayer, Andrew R ^f,g,h   Bellgowan, Patrick S F ⁱ   Meier, Timothy B ^a,f  

^a LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^b UNIVERSITY OF TULSA   (United States)

^c University of Oklahoma Tulsa College of Medicine   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^e OKLAHOMA STATE UNIVERSITY   (United States)

^f MIND RESEARCH NETWORK   (United States)

^g UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NEW MEXICO   (United States)

ⁱ NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENINE; QUINOLINIC ACID;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCUSSION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FOOTBALL; HUMAN; KYNURENINE BLOOD LEVEL; LONGITUDINAL STUDY; MALE; METABOLITE; MOOD DISORDER; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUINOLINIC ACID BLOOD LEVEL; SPORT INJURY; SYMPTOM; ATHLETIC INJURIES; BLOOD; BRAIN CONCUSSION; FOLLOW UP; INJURIES; MOOD DISORDERS; NEUROLOGIC EXAMINATION; POST-CONCUSSION SYNDROME; PSYCHOLOGY; REFERENCE VALUE; STATISTICS; YOUNG ADULT;

ATHLETIC INJURIES; BRAIN CONCUSSION; FOLLOW-UP STUDIES; FOOTBALL; HUMANS; KYNURENINE; MALE; MOOD DISORDERS; NEUROLOGIC EXAMINATION; POST-CONCUSSION SYNDROME; REFERENCE VALUES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84940186208     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2015-311369     Document Type: Article

References (32)

1. Singh R, Meier TB, Kuplicki R, et al. Relationship of collegiate football experience and concussion with hippocampal volume and cognitive outcomes. JAMA 2014;311:1883-8.
2. McKee AC, Stern RA, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013;136(Pt 1):43-64.
3. Stamm JM, Bourlas AP, Baugh CM, et al. Age of first exposure to football and later-life cognitive impairment in former NFL players. Neurology 2015;84:1114-20.
4. McCrea M, Guskiewicz KM, Marshall SW, et al. Acute effects and recovery time following concussion in collegiate football players: the NCAA Concussion Study. JAMA 2003;290:2556-63.
5. Amaral M, Outeiro TF, Scrutton NS, et al. The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease. J Mol Med 2013;91:705-13.
6. Blaylock RL, Maroon J. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-a unifying hypothesis. Surg Neurol Int 2011;2:107.
7. Giza CC, Hovda DA. The new neurometabolic cascade of concussion. Neurosurgery 2014;75(Suppl 4):S24-33.
8. Patterson ZR, Holahan MR. Understanding the neuroinflammatory response following concussion to develop treatment strategies. Front Cell Neurosci 2012;6:58.
9. Schwarcz R, Bruno JP, Muchowski PJ, et al. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 2012;13:465-77.
10. Savitz J, Drevets WC, Smith CM, et al. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 2015;40:463-71.
11. Savitz J, Dantzer R, Wurfel BE, et al. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 2015;52:200-11.
12. Savitz J, Drevets WC, Wurfel BE, et al. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun 2015;46:55-9.
13. Bay-Richter C, Linderholm KR, Lim CK, et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 2015;43:110-17.
14. Steiner J, Walter M, Gos T, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 2011;8:94.
15. Bell MJ, Kochanek PM, Heyes MP, et al. Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med 1999;27:493-7.
16. Sinz EH, Kochanek PM, Heyes MP, et al. Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab 1998;18:610-15.
17. Kontos AP, Covassin T, Elbin RJ, et al. Depression and neurocognitive performance after concussion among male and female high school and collegiate athletes. Arch Phys Med Rehabil 2012;93:1751-6.
18. McCrory P, Meeuwisse WH, Aubry M, et al. Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport held in Zurich, November 2012. Br J Sports Med 2013;47:250-8.
19. Meier TB, Bellgowan PS, Singh R, et al. Recovery of cerebral blood flow following sports-related concussion. JAMA Neurol 2015;72:530-8.
20. Cernich A, Reeves D, Sun W, et al. Automated neuropsychological assessment metrics sports medicine battery. Applied Neuropsychology 2007;22(Suppl 1):S101-14.
21. Bombardier CH, Fann JR, Temkin NR, et al. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA 2010;303:1938-45.
22. Mackay GM, Forrest CM, Stoy N, et al. Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol 2006;13:30-42.
23. Schwarcz R, Whetsell WO, Jr., Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983;219:316-18.
24. Perkins MN, Stone TW. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 1982;247:184-7.
25. Suma T, Koshinaga M, Fukushima M, et al. Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury. Neurol Res 2008;30:420-9.
26. Hicks RR, Smith DH, Gennarelli TA, et al. Kynurenate is neuroprotective following experimental brain injury in the rat. Brain Res 1994;655:91-6.
27. Smith DH, Okiyama K, Thomas MJ, et al. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci 1993;13:5383-92.
28. Meier TB, Brummel BJ, Singh R, et al. The underreporting of self-reported symptoms following sports-related concussion. J Sci Med Sport 2014 Jul 24. pii: S1440-2440(14)00134-0.
29. McCrea M, Hammeke T, Olsen G, et al. Unreported concussion in high school football players: implications for prevention. Clin J Sport Med 2004;14:13-17.
30. Guskiewicz KM, Marshall SW, Bailes J, et al. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 2005;57:719-26; discussion 19-26.
31. Guskiewicz KM, Marshall SW, Bailes J, et al. Recurrent concussion and risk of depression in retired professional football players. Med Sci Sports Exerc 2007;39:903-9.
32. Perez-Polo JR, Rea HC, Johnson KM, et al. Inflammatory consequences in a rodent model of mild traumatic brain injury. J Neurotrauma 2013;30:727-40.